Coalition for Pulmonary Fibrosis Company Profile

01:25 EDT 25th March 2019 | BioPortfolio

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

News Articles [1009 Associated News Articles listed on BioPortfolio]

Global Idiopathic Pulmonary Fibrosis Pipeline Insight 2018 by Development Stage, Mechanism of ...

DUBLIN, Jan 9, 2019 /PRNewswire/ -- The "Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2018" drug pipelines has been added to's offering. Idiopathic Pulmonary Fibrosis Read...

Experimental findings support a connection between mucins in the lung and pulmonary fibrosis

A team of investigators has identified a connection between mucus in the small airways and pulmonary fibrosis.

FDA orphan status granted to AZ's idiopathic pulmonary fibrosis drug

AstraZeneca's saracatinib, which is being developed as a treatment for patients with idiopathic pulmonary fibrosis, was given -More- 

FDA fast-tracks FibroGen's idiopathic pulmonary fibrosis therapy

FibroGen's pamrevlumab, being developed to treat patients with idiopathic pulmonary fibrosis, was granted fast-track designat -More- 

Anti-Reflux Surgery Promising in Idiopathic Pulmonary Fibrosis

MONDAY, Oct. 1, 2018 -- Laparoscopic antireflux surgery is safe and well-tolerated in patients with idiopathic pulmonary fibrosis (IPF) and abnormal acid gastroesophageal reflux (GER), according to a ...

Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival

Pirfenidone increased 3-year survival in patients with idiopathic pulmonary fibrosis, resulting in a 30% survival benefit compared with those not treated with antifibrotic agents, a study found. Med...

US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis

The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for saracatinib, a potential new medicine for the treatment of idiopathic pulmonary fibrosis (IPF), a type of lung d...

CU Anschutz researchers discover important breakthrough in pulmonary fibrosis

(University of Colorado Anschutz Medical Campus) A team of investigators led by members of the University of Colorado School of Medicine faculty at CU Anschutz Medical Campus has identified a connecti...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Na [bayer healthcare, inc.]


Pulmozyme [genentech, inc.]

These highlights do not include all the information needed to use PULMOZYME safely and effectively. See full prescribing information for PULMOZYME. PULMOZYME (dornase alfa) inhalation solution, for in...

Bleomycin [northstar rx llc]

Bleomycin for Injection, USP

Bleomycin [meitheal pharmaceuticals inc.]

Bleomycin for Injection, USP

Bleomycin [fresenius kabi usa, llc]

Bleomycin for Injection, USP

PubMed Articles [2337 Associated PubMed Articles listed on BioPortfolio]

Translational research in pulmonary fibrosis.

Pulmonary fibrosis refers to the development of diffuse parenchymal abnormalities in the lung that cause dyspnea, cough, hypoxemia, and impair gas exchange, ultimately leading to respiratory failure. ...

Antineutrophil Cytoplasmic Antibody-Associated Lung Fibrosis.

Pulmonary fibrosis is observed in a substantial number of patients with ANCA-associated vasculitis (AAV), 15% in a recent German series, and may be more frequent in Asian populations. ANCA are usually...

Distribution of emphysema and fibrosis in idiopathic pulmonary fibrosis with coexisting emphysema.

Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome that results from tobacco smoking. Emphysema and fibrosis in CPFE patients have been considered to exist separately, with emphysema in th...

A Novel Variant of Desmoplakin Is Potentially Associated with Silicosis Risk.

Two genome-wide association studies and one sequencing study have coincidently reported significant associations of single nucleotide polymorphisms (SNPs) in the desmoplakin (DSP) gene with the risk o...

Prodigiosin Alleviates Pulmonary Fibrosis Through Inhibiting miRNA-410 and TGF-β1/ADAMTS-1 Signaling Pathway.

Pulmonary fibrosis is a common outcome of various interstitial lung diseases. Prodigiosin (PG) is a series of red pigment with methoxypyrrole ring. This studyinvestigates therole of prodigiosin in pul...

Clinical Trials [4550 Associated Clinical Trials listed on BioPortfolio]

A Linkage and Association Study in Pulmonary Fibrosis

The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose in...

Pirfenidone for the Treatment of Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)

To assess the long-term safety and efficacy of oral pirfenidone in doses of up to 40 mg/kg/d in a limited number of patients with pulmonary fibrosis/idiopathic pulmonary fibrosis (PF/IPF)

Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis

The inclusion of Pulmonary Rehabilitation (PR) as part of the management of pulmonary fibrosis although being highly recommended and recommended in guidelines still sees studies exploring ...

Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)

This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy perfo...

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

Endothelin-1 (ET-1) is expressed in a variety of pulmonary pathological conditions including pulmonary vascular disease and pulmonary fibrosis. Bosentan (an oral dual ET-1 receptor antago...

Companies [469 Associated Companies listed on BioPortfolio]

Coalition for Pulmonary Fibrosis

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. App...

The Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation is 501©(3) organization, whose mission is to find a cure for idiopathic pulmonary fibrosis (IPF) by funding research, advocating for IPF issues, promoting disease aw...

ZappRx, Inc.

ZappRx streamlines the complex process required to order specialty medications, increasing efficiencies when collecting and maintaining the myriad requisite information for specia...

Pharmaxis Ltd

Pharmaxis (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory diso...


ZappRx simplifies the complex process required to order specialty medications, making it easier to collect and save all of the information required to order a prescription — ...

More Information about "Coalition for Pulmonary Fibrosis" on BioPortfolio

We have published hundreds of Coalition for Pulmonary Fibrosis news stories on BioPortfolio along with dozens of Coalition for Pulmonary Fibrosis Clinical Trials and PubMed Articles about Coalition for Pulmonary Fibrosis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Coalition for Pulmonary Fibrosis Companies in our database. You can also find out about relevant Coalition for Pulmonary Fibrosis Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Corporate Database Quicklinks

Searches Linking to this Company Record